We are live on ! Find out more
BCM

Bayesian Capital Management Portfolio holdings

AUM $81.9M
1-Year Est. Return 26.59%
This Fund
S&P 500
This Quarter Est. Return
+10.07%
1 Year Est. Return
+26.59%
3 Year Est. Return
+112.98%
5 Year Est. Return
+129.77%
10 Year Est. Return
+1,146.62%
AUM
$419M
AUM Growth
+$148M
Cap. Flow
+$129M
Cap. Flow %
30.92%
Top 10 Hldgs %
12.65%
Holding
735
New
336
Increased
76
Reduced
46
Closed
277

Top Buys

Rank Stock Value
1
ACN icon
Accenture
ACN
+$6.95M
2
AAPL icon
Apple
AAPL
+$6.94M
3
COL
Rockwell Collins
COL
+$5.18M
4
CCL icon
Carnival Corporation Ltd
CCL
+$5.04M
5
TAP icon
Molson Coors Class B
TAP
+$4.99M

Top Sells

Rank Stock Value
1
NKE icon
Nike
NKE
+$9.64M
2
AYI icon
Acuity Brands
AYI
+$4.57M
3
MDLZ icon
Mondelez International
MDLZ
+$3.38M
4
COST icon
Costco
COST
+$2.98M
5
INTU icon
Intuit
INTU
+$2.8M

Sector Composition

Rank Sector Weight
1 Technology 17.55%
2 Consumer Discretionary 17.53%
3 Healthcare 13.84%
4 Industrials 10.3%
5 Consumer Staples 10.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CENTA icon
426
Central Garden & Pet Co Class A
CENTA
$2.39B
$204K 0.05%
+6,865
New +$182K
CAL icon
427
Caleres
CAL
$420M
$203K 0.05%
+6,646
New +$180K
ACHN
428
DELISTED
Achillion Pharmaceuticals
ACHN
$203K 0.05%
+45,106
New +$200K
PNK
429
DELISTED
Pinnacle Entertainment Inc.
PNK
$202K 0.05%
+9,500
New +$187K
EVRI
430
DELISTED
Everi Holdings
EVRI
$191K 0.05%
25,163
+14,800
+143% +$111K
INVA icon
431
Innoviva
INVA
$1.57B
$191K 0.05%
+13,500
New +$178K
TVRD
432
Tvardi Therapeutics
TVRD
$23.8M
$190K 0.05%
+386
New +$193K
INOV
433
DELISTED
Inovalon Holdings, Inc. Class A Common Stock
INOV
$185K 0.04%
+10,873
New +$152K
CO
434
DELISTED
Global Cord Blood Corporation
CO
$183K 0.04%
+16,460
New +$193K
HDSN
435
Hudson Technologies
HDSN
$263M
$178K 0.04%
+22,844
New +$198K
ARRY
436
DELISTED
Array Biopharma Inc
ARRY
$173K 0.04%
14,100
-20,100
-59% -$187K
ZNGA
437
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
$172K 0.04%
45,400
-1,200
-3% -$4.42K
PGRE
438
DELISTED
Paramount Group
PGRE
$165K 0.04%
+10,300
New +$164K
SSRM icon
439
SSR Mining
SSRM
$5.45B
$165K 0.04%
+15,571
New +$159K
GPOR
440
DELISTED
Gulfport Energy Corp.
GPOR
$153K 0.04%
+10,660
New +$138K
LTM
441
DELISTED
LATAM Airlines Group S.A American Depositary Shares (Each representing 1 Common Share)
LTM
$152K 0.04%
+11,457
New +$142K
ATEN icon
442
A10 Networks
ATEN
$2.41B
$151K 0.04%
+20,012
New +$136K
PIR
443
DELISTED
Pier 1 Imports, Inc.
PIR
$149K 0.04%
+1,780
New +$159K
KGC icon
444
Kinross Gold
KGC
$28.6B
$147K 0.04%
34,700
-13,100
-27% -$56K
ITUB icon
445
Itaú Unibanco
ITUB
$92.3B
$141K 0.03%
+21,233
New +$130K
DENN
446
DELISTED
Denny's
DENN
$134K 0.03%
+10,768
New +$128K
MX icon
447
Magnachip Semiconductor
MX
$126M
$132K 0.03%
+11,609
New +$128K
GFI icon
448
Gold Fields
GFI
$29.4B
$128K 0.03%
+29,800
New +$122K
MDXG icon
449
MiMedx Group
MDXG
$635M
$125K 0.03%
+10,500
New +$156K
PDLI
450
DELISTED
PDL BioPharma, Inc.
PDLI
$122K 0.03%
+35,875
New +$99.8K
16 17
18
19 20

Similar funds

KL
Khall LLC San Francisco, California $82M AUM
FWS
FinDec Wealth Services Stockton, California $81.8M AUM 13.5% 1-Year Est. Return
FRIHG
Fund Resources Investment Holding Group Hong Kong $81.7M AUM
AGFVA
Accel Growth Fund V Associates Palo Alto, California $81.7M AUM 29.05% 1-Year Est. Return
1C
1060 Capital Denver, Colorado $82.3M AUM 146.68% 1-Year Est. Return
MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
FLC
Fifth Lane Capital Austin, Texas $82.3M AUM 26.09% 1-Year Est. Return
APW
Axim Planning & Wealth Springboro, Ohio $82.4M AUM 28.66% 1-Year Est. Return

Bayesian Capital Management's Q3 2017 Portfolio in Review

As of Q3 2017, Bayesian Capital Management held 735 positions worth $419M, up 54% from $271M the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Bayesian Capital Management deployed $129M of net new capital in Q3 2017, opening 336 new positions and adding to 76 existing holdings. Its largest new stake was Accenture: 53,319 shares worth $7.2M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 18% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Vodafone, an estimated $1.72M trimmed.

  • Bayesian Capital Management's largest Q3 2017 buy was Accenture: 53,319 shares worth $7.2M.
  • Bayesian Capital Management added most to Rockwell Collins in Q3 2017, an estimated $5.18M increase.
  • Bayesian Capital Management's biggest Q3 2017 reduction was Vodafone, cutting an estimated $1.72M.
  • Bayesian Capital Management fully exited Nike in Q3 2017, selling an estimated $9.64M.
  • Bayesian Capital Management's ten largest holdings make up 13% of its $419M portfolio in Q3 2017.
  • Bayesian Capital Management opened 336 new positions and closed 277 in Q3 2017.
  • Bayesian Capital Management's portfolio value rose 54% quarter-over-quarter to $419M.

Based on Bayesian Capital Management's 13F filing for Q3 2017, filed 14 Nov 2017.